You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bladder overactivity

Showing 1 - 25 of 3,201
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

BPH, Intravesical Botox, ThuLEP Trial (Thulium Laser Enucleation of the Prostate (ThuLEP), Intravesical Botox injection)

Not yet recruiting
  • BPH
  • +4 more
  • Thulium Laser Enucleation of the Prostate (ThuLEP)
  • Intravesical Botox injection
  • (no location specified)
Jun 11, 2023

Spinal Cord Injuries, Neurogenic Bladder, Neurogenic Detrusor Overactivity Trial (Neuromodulation)

Not yet recruiting
  • Spinal Cord Injuries
  • +3 more
  • Neuromodulation
  • (no location specified)
Aug 12, 2022

Urinary Bladder, Overactive, Urodynamics, Effect of Drug Trial in Taipei (Intradetrusor Botox® (onabotulinumtoxinA) injection,

Recruiting
  • Urinary Bladder, Overactive
  • +2 more
  • Intradetrusor Botox® (onabotulinumtoxinA) injection
  • Combine Mirabegron and Solifenacin.
  • Taipei, Taiwan
    Mackay Memorial Hospital
Jul 29, 2023

Neurogenic Bladder, Lower Urinary Tract Symptoms, Overactive Bladder Trial (Standard number of injection sites, Reduced number

Not yet recruiting
  • Neurogenic Bladder
  • +4 more
  • Standard number of injection sites
  • Reduced number of injection sites
  • (no location specified)
Sep 22, 2023

Triggered Sacral Neuromodulation for Neurogenic Bladder

Recruiting
  • Urinary Incontinence
  • Urinary Bladder, Neurogenic
  • UroMonitor
  • ASCU
  • Cleveland, Ohio
    Louis Stokes VA Medical Center, Cleveland, OH
Nov 15, 2022

Developing a Simple Test to Diagnose Overactive Bladder

Not yet recruiting
  • Overactive Bladder
  • +2 more
  • Urodynamics aka filling cystometry
  • (no location specified)
Oct 7, 2022

Spinal Cord Injuries, Urinary Bladder, Overactive Trial in Nesoddtangen, Oslo (Onabotulinumtoxin A, Placebo)

Completed
  • Spinal Cord Injuries
  • Urinary Bladder, Overactive
  • Onabotulinumtoxin A
  • Placebo
  • Nesoddtangen, Norway
  • +1 more
Nov 22, 2022

Neurogenic Detrusor Overactivity Trial in Worldwide (mirabegron)

Not yet recruiting
  • Neurogenic Detrusor Overactivity
  • Palo Alto, California
  • +11 more
Jan 16, 2023

Neurogenic Detrusor Overactivity Trial (Vibegron)

Not yet recruiting
  • Neurogenic Detrusor Overactivity
  • (no location specified)
Aug 4, 2022

Overactive Bladder, Overactive Detrusor, Overactive Bladder Syndrome Trial in Cambridge (Bicarbonate protocol, Standard

Recruiting
  • Overactive Bladder
  • +4 more
  • Bicarbonate protocol
  • Standard protocol
  • Cambridge, Massachusetts
    Boston Urogynecology Associates
Mar 1, 2022

Overactive Bladder, Neurogenic Detrusor Overactivity Trial in Aalborg, Aarhus, Warsaw (mirabegron)

Completed
  • Overactive Bladder
  • Neurogenic Detrusor Overactivity
  • Aalborg, Denmark
  • +2 more
Jun 28, 2021

Neurogenic Detrusor Overactivity Trial in Colombia, United States (Darifenacin)

Terminated
Has Results
  • Neurogenic Detrusor Overactivity
  • San Diego, California
  • +11 more
May 13, 2022

BO and DO in Cystocele Before and After Cystocele Repair

Completed
  • Bladder Oversensitivity
  • Detrusor, Overactive
  • Cystocele repair
  • Taipei, Taiwan
    National Taiwan University Hospital
Jul 20, 2021

USI and/or DO in Cystocele Before and After Cystocele Repair

Completed
  • Urodynamic Stress Incontinence
  • Detrusor Overactivity
  • Cystocele repair
  • Taipei, Taiwan
    National Taiwan University Hospital
Jul 20, 2021

Neurogenic Detrusor Overactivity, Overactive Bladder, Pharmacokinetics of Mirabegron Trial in Worldwide (Mirabegron)

Completed
  • Neurogenic Detrusor Overactivity
  • +2 more
  • Edegem, Belgium
  • +12 more
Jul 13, 2021

Neurogenic Detrusor Overactivity Trial in Worldwide (Mirabegron)

Completed
Has Results
  • Neurogenic Detrusor Overactivity
  • Randwick, New South Wales, Australia
  • +31 more
Sep 21, 2022

Portable Bladder Scanner to Determine Age/ Volume Specific

Completed
  • Neurogenic Bladder
  • +2 more
  • Bladder scan
  • Seoul, Korea, Republic of
    Seoul National University Hospital
May 11, 2021

Urinary Bladder, Overactive Trial in Japan (GSK1358820, Placebo)

Completed
Has Results
  • Urinary Bladder, Overactive
  • Aomori, Japan
  • +8 more
Jul 13, 2021

Neurogenic Urinary Bladder, Neurogenic Bladder Disorder, Neurogenic Dysfunction of the Urinary Bladder Trial in Murnau,

Terminated
  • Neurogenic Urinary Bladder
  • +4 more
  • Murnau, Germany
  • +2 more
Dec 11, 2020

Overactive Bladder Trial in Saint-Petersburg (Transvertebral magnetic stimulation)

Recruiting
  • Overactive Bladder
  • Transvertebral magnetic stimulation
  • Saint-Petersburg, Russian Federation
    Joint-Stock Company "North-Western Centre of Evidence-Based Medi
Oct 1, 2020

Parkinson's Disease, Overactive Bladder, Onabotulinumtoxin A Trial in Guangzhou (oral anti-Parkinson drugs and injection of

Recruiting
  • Parkinson's Disease
  • +2 more
  • oral anti-Parkinson drugs and injection of botulinum toxin
  • oral anti-Parkinson's drugs
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Aug 16, 2023

Urinary Bladder, Neurogenic Trial in Japan (Fesoterodine PR 4 mg, Fesoterodine PR 8 mg, Fesoterodine BIC 2 mg)

Completed
Has Results
  • Urinary Bladder, Neurogenic
  • Fesoterodine PR 4 mg
  • +3 more
  • Obu, Aichi, Japan
  • +6 more
Nov 25, 2020

Overactive Bladder Syndrome, Detrusor Overactivity Trial (Mirabegron 50 MG, Solifenacin Succinate 5 MG)

Not yet recruiting
  • Overactive Bladder Syndrome
  • Detrusor Overactivity
  • Mirabegron 50 MG
  • Solifenacin Succinate 5 MG
  • (no location specified)
Jan 25, 2021

Neurogenic Detrusor Overactivity Trial in Worldwide (Rec 0/0438 1 mg or Rec 0/0438 2 mg, )

Completed
  • Neurogenic Detrusor Overactivity
  • Rec 0/0438 1 mg or Rec 0/0438 2 mg
  • placebo
  • Praha, Czechia
  • +8 more
Jan 26, 2021

Prostate Adenocarcinoma Trial in Philadelphia (Fesoterodine, Placebo oral tablet)

Completed
  • Prostate Adenocarcinoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 24, 2020